Cargando…

Deploying unsupervised clustering analysis to derive clinical phenotypes and risk factors associated with mortality risk in 2022 critically ill patients with COVID-19 in Spain

BACKGROUND: The identification of factors associated with Intensive Care Unit (ICU) mortality and derived clinical phenotypes in COVID-19 patients could help for a more tailored approach to clinical decision-making that improves prognostic outcomes. METHODS: Prospective, multicenter, observational s...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodríguez, Alejandro, Ruiz-Botella, Manuel, Martín-Loeches, Ignacio, Jimenez Herrera, María, Solé-Violan, Jordi, Gómez, Josep, Bodí, María, Trefler, Sandra, Papiol, Elisabeth, Díaz, Emili, Suberviola, Borja, Vallverdu, Montserrat, Mayor-Vázquez, Eric, Albaya Moreno, Antonio, Canabal Berlanga, Alfonso, Sánchez, Miguel, del Valle Ortíz, María, Ballesteros, Juan Carlos, Martín Iglesias, Lorena, Marín-Corral, Judith, López Ramos, Esther, Hidalgo Valverde, Virginia, Vidaur Tello, Loreto Vidaur, Sancho Chinesta, Susana, Gonzáles de Molina, Francisco Javier, Herrero García, Sandra, Sena Pérez, Carmen Carolina, Pozo Laderas, Juan Carlos, Rodríguez García, Raquel, Estella, Angel, Ferrer, Ricard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7883885/
https://www.ncbi.nlm.nih.gov/pubmed/33588914
http://dx.doi.org/10.1186/s13054-021-03487-8
_version_ 1783651304262860800
author Rodríguez, Alejandro
Ruiz-Botella, Manuel
Martín-Loeches, Ignacio
Jimenez Herrera, María
Solé-Violan, Jordi
Gómez, Josep
Bodí, María
Trefler, Sandra
Papiol, Elisabeth
Díaz, Emili
Suberviola, Borja
Vallverdu, Montserrat
Mayor-Vázquez, Eric
Albaya Moreno, Antonio
Canabal Berlanga, Alfonso
Sánchez, Miguel
del Valle Ortíz, María
Ballesteros, Juan Carlos
Martín Iglesias, Lorena
Marín-Corral, Judith
López Ramos, Esther
Hidalgo Valverde, Virginia
Vidaur Tello, Loreto Vidaur
Sancho Chinesta, Susana
Gonzáles de Molina, Francisco Javier
Herrero García, Sandra
Sena Pérez, Carmen Carolina
Pozo Laderas, Juan Carlos
Rodríguez García, Raquel
Estella, Angel
Ferrer, Ricard
author_facet Rodríguez, Alejandro
Ruiz-Botella, Manuel
Martín-Loeches, Ignacio
Jimenez Herrera, María
Solé-Violan, Jordi
Gómez, Josep
Bodí, María
Trefler, Sandra
Papiol, Elisabeth
Díaz, Emili
Suberviola, Borja
Vallverdu, Montserrat
Mayor-Vázquez, Eric
Albaya Moreno, Antonio
Canabal Berlanga, Alfonso
Sánchez, Miguel
del Valle Ortíz, María
Ballesteros, Juan Carlos
Martín Iglesias, Lorena
Marín-Corral, Judith
López Ramos, Esther
Hidalgo Valverde, Virginia
Vidaur Tello, Loreto Vidaur
Sancho Chinesta, Susana
Gonzáles de Molina, Francisco Javier
Herrero García, Sandra
Sena Pérez, Carmen Carolina
Pozo Laderas, Juan Carlos
Rodríguez García, Raquel
Estella, Angel
Ferrer, Ricard
author_sort Rodríguez, Alejandro
collection PubMed
description BACKGROUND: The identification of factors associated with Intensive Care Unit (ICU) mortality and derived clinical phenotypes in COVID-19 patients could help for a more tailored approach to clinical decision-making that improves prognostic outcomes. METHODS: Prospective, multicenter, observational study of critically ill patients with confirmed COVID-19 disease and acute respiratory failure admitted from 63 ICUs in Spain. The objective was to utilize an unsupervised clustering analysis to derive clinical COVID-19 phenotypes and to analyze patient’s factors associated with mortality risk. Patient features including demographics and clinical data at ICU admission were analyzed. Generalized linear models were used to determine ICU morality risk factors. The prognostic models were validated and their performance was measured using accuracy test, sensitivity, specificity and ROC curves. RESULTS: The database included a total of 2022 patients (mean age 64 [IQR 5–71] years, 1423 (70.4%) male, median APACHE II score (13 [IQR 10–17]) and SOFA score (5 [IQR 3–7]) points. The ICU mortality rate was 32.6%. Of the 3 derived phenotypes, the A (mild) phenotype (537; 26.7%) included older age (< 65 years), fewer abnormal laboratory values and less development of complications, B (moderate) phenotype (623, 30.8%) had similar characteristics of A phenotype but were more likely to present shock. The C (severe) phenotype was the most common (857; 42.5%) and was characterized by the interplay of older age (> 65 years), high severity of illness and a higher likelihood of development shock. Crude ICU mortality was 20.3%, 25% and 45.4% for A, B and C phenotype respectively. The ICU mortality risk factors and model performance differed between whole population and phenotype classifications. CONCLUSION: The presented machine learning model identified three clinical phenotypes that significantly correlated with host-response patterns and ICU mortality. Different risk factors across the whole population and clinical phenotypes were observed which may limit the application of a “one-size-fits-all” model in practice.
format Online
Article
Text
id pubmed-7883885
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-78838852021-02-16 Deploying unsupervised clustering analysis to derive clinical phenotypes and risk factors associated with mortality risk in 2022 critically ill patients with COVID-19 in Spain Rodríguez, Alejandro Ruiz-Botella, Manuel Martín-Loeches, Ignacio Jimenez Herrera, María Solé-Violan, Jordi Gómez, Josep Bodí, María Trefler, Sandra Papiol, Elisabeth Díaz, Emili Suberviola, Borja Vallverdu, Montserrat Mayor-Vázquez, Eric Albaya Moreno, Antonio Canabal Berlanga, Alfonso Sánchez, Miguel del Valle Ortíz, María Ballesteros, Juan Carlos Martín Iglesias, Lorena Marín-Corral, Judith López Ramos, Esther Hidalgo Valverde, Virginia Vidaur Tello, Loreto Vidaur Sancho Chinesta, Susana Gonzáles de Molina, Francisco Javier Herrero García, Sandra Sena Pérez, Carmen Carolina Pozo Laderas, Juan Carlos Rodríguez García, Raquel Estella, Angel Ferrer, Ricard Crit Care Research BACKGROUND: The identification of factors associated with Intensive Care Unit (ICU) mortality and derived clinical phenotypes in COVID-19 patients could help for a more tailored approach to clinical decision-making that improves prognostic outcomes. METHODS: Prospective, multicenter, observational study of critically ill patients with confirmed COVID-19 disease and acute respiratory failure admitted from 63 ICUs in Spain. The objective was to utilize an unsupervised clustering analysis to derive clinical COVID-19 phenotypes and to analyze patient’s factors associated with mortality risk. Patient features including demographics and clinical data at ICU admission were analyzed. Generalized linear models were used to determine ICU morality risk factors. The prognostic models were validated and their performance was measured using accuracy test, sensitivity, specificity and ROC curves. RESULTS: The database included a total of 2022 patients (mean age 64 [IQR 5–71] years, 1423 (70.4%) male, median APACHE II score (13 [IQR 10–17]) and SOFA score (5 [IQR 3–7]) points. The ICU mortality rate was 32.6%. Of the 3 derived phenotypes, the A (mild) phenotype (537; 26.7%) included older age (< 65 years), fewer abnormal laboratory values and less development of complications, B (moderate) phenotype (623, 30.8%) had similar characteristics of A phenotype but were more likely to present shock. The C (severe) phenotype was the most common (857; 42.5%) and was characterized by the interplay of older age (> 65 years), high severity of illness and a higher likelihood of development shock. Crude ICU mortality was 20.3%, 25% and 45.4% for A, B and C phenotype respectively. The ICU mortality risk factors and model performance differed between whole population and phenotype classifications. CONCLUSION: The presented machine learning model identified three clinical phenotypes that significantly correlated with host-response patterns and ICU mortality. Different risk factors across the whole population and clinical phenotypes were observed which may limit the application of a “one-size-fits-all” model in practice. BioMed Central 2021-02-15 /pmc/articles/PMC7883885/ /pubmed/33588914 http://dx.doi.org/10.1186/s13054-021-03487-8 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Rodríguez, Alejandro
Ruiz-Botella, Manuel
Martín-Loeches, Ignacio
Jimenez Herrera, María
Solé-Violan, Jordi
Gómez, Josep
Bodí, María
Trefler, Sandra
Papiol, Elisabeth
Díaz, Emili
Suberviola, Borja
Vallverdu, Montserrat
Mayor-Vázquez, Eric
Albaya Moreno, Antonio
Canabal Berlanga, Alfonso
Sánchez, Miguel
del Valle Ortíz, María
Ballesteros, Juan Carlos
Martín Iglesias, Lorena
Marín-Corral, Judith
López Ramos, Esther
Hidalgo Valverde, Virginia
Vidaur Tello, Loreto Vidaur
Sancho Chinesta, Susana
Gonzáles de Molina, Francisco Javier
Herrero García, Sandra
Sena Pérez, Carmen Carolina
Pozo Laderas, Juan Carlos
Rodríguez García, Raquel
Estella, Angel
Ferrer, Ricard
Deploying unsupervised clustering analysis to derive clinical phenotypes and risk factors associated with mortality risk in 2022 critically ill patients with COVID-19 in Spain
title Deploying unsupervised clustering analysis to derive clinical phenotypes and risk factors associated with mortality risk in 2022 critically ill patients with COVID-19 in Spain
title_full Deploying unsupervised clustering analysis to derive clinical phenotypes and risk factors associated with mortality risk in 2022 critically ill patients with COVID-19 in Spain
title_fullStr Deploying unsupervised clustering analysis to derive clinical phenotypes and risk factors associated with mortality risk in 2022 critically ill patients with COVID-19 in Spain
title_full_unstemmed Deploying unsupervised clustering analysis to derive clinical phenotypes and risk factors associated with mortality risk in 2022 critically ill patients with COVID-19 in Spain
title_short Deploying unsupervised clustering analysis to derive clinical phenotypes and risk factors associated with mortality risk in 2022 critically ill patients with COVID-19 in Spain
title_sort deploying unsupervised clustering analysis to derive clinical phenotypes and risk factors associated with mortality risk in 2022 critically ill patients with covid-19 in spain
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7883885/
https://www.ncbi.nlm.nih.gov/pubmed/33588914
http://dx.doi.org/10.1186/s13054-021-03487-8
work_keys_str_mv AT rodriguezalejandro deployingunsupervisedclusteringanalysistoderiveclinicalphenotypesandriskfactorsassociatedwithmortalityriskin2022criticallyillpatientswithcovid19inspain
AT ruizbotellamanuel deployingunsupervisedclusteringanalysistoderiveclinicalphenotypesandriskfactorsassociatedwithmortalityriskin2022criticallyillpatientswithcovid19inspain
AT martinloechesignacio deployingunsupervisedclusteringanalysistoderiveclinicalphenotypesandriskfactorsassociatedwithmortalityriskin2022criticallyillpatientswithcovid19inspain
AT jimenezherreramaria deployingunsupervisedclusteringanalysistoderiveclinicalphenotypesandriskfactorsassociatedwithmortalityriskin2022criticallyillpatientswithcovid19inspain
AT soleviolanjordi deployingunsupervisedclusteringanalysistoderiveclinicalphenotypesandriskfactorsassociatedwithmortalityriskin2022criticallyillpatientswithcovid19inspain
AT gomezjosep deployingunsupervisedclusteringanalysistoderiveclinicalphenotypesandriskfactorsassociatedwithmortalityriskin2022criticallyillpatientswithcovid19inspain
AT bodimaria deployingunsupervisedclusteringanalysistoderiveclinicalphenotypesandriskfactorsassociatedwithmortalityriskin2022criticallyillpatientswithcovid19inspain
AT treflersandra deployingunsupervisedclusteringanalysistoderiveclinicalphenotypesandriskfactorsassociatedwithmortalityriskin2022criticallyillpatientswithcovid19inspain
AT papiolelisabeth deployingunsupervisedclusteringanalysistoderiveclinicalphenotypesandriskfactorsassociatedwithmortalityriskin2022criticallyillpatientswithcovid19inspain
AT diazemili deployingunsupervisedclusteringanalysistoderiveclinicalphenotypesandriskfactorsassociatedwithmortalityriskin2022criticallyillpatientswithcovid19inspain
AT suberviolaborja deployingunsupervisedclusteringanalysistoderiveclinicalphenotypesandriskfactorsassociatedwithmortalityriskin2022criticallyillpatientswithcovid19inspain
AT vallverdumontserrat deployingunsupervisedclusteringanalysistoderiveclinicalphenotypesandriskfactorsassociatedwithmortalityriskin2022criticallyillpatientswithcovid19inspain
AT mayorvazquezeric deployingunsupervisedclusteringanalysistoderiveclinicalphenotypesandriskfactorsassociatedwithmortalityriskin2022criticallyillpatientswithcovid19inspain
AT albayamorenoantonio deployingunsupervisedclusteringanalysistoderiveclinicalphenotypesandriskfactorsassociatedwithmortalityriskin2022criticallyillpatientswithcovid19inspain
AT canabalberlangaalfonso deployingunsupervisedclusteringanalysistoderiveclinicalphenotypesandriskfactorsassociatedwithmortalityriskin2022criticallyillpatientswithcovid19inspain
AT sanchezmiguel deployingunsupervisedclusteringanalysistoderiveclinicalphenotypesandriskfactorsassociatedwithmortalityriskin2022criticallyillpatientswithcovid19inspain
AT delvalleortizmaria deployingunsupervisedclusteringanalysistoderiveclinicalphenotypesandriskfactorsassociatedwithmortalityriskin2022criticallyillpatientswithcovid19inspain
AT ballesterosjuancarlos deployingunsupervisedclusteringanalysistoderiveclinicalphenotypesandriskfactorsassociatedwithmortalityriskin2022criticallyillpatientswithcovid19inspain
AT martiniglesiaslorena deployingunsupervisedclusteringanalysistoderiveclinicalphenotypesandriskfactorsassociatedwithmortalityriskin2022criticallyillpatientswithcovid19inspain
AT marincorraljudith deployingunsupervisedclusteringanalysistoderiveclinicalphenotypesandriskfactorsassociatedwithmortalityriskin2022criticallyillpatientswithcovid19inspain
AT lopezramosesther deployingunsupervisedclusteringanalysistoderiveclinicalphenotypesandriskfactorsassociatedwithmortalityriskin2022criticallyillpatientswithcovid19inspain
AT hidalgovalverdevirginia deployingunsupervisedclusteringanalysistoderiveclinicalphenotypesandriskfactorsassociatedwithmortalityriskin2022criticallyillpatientswithcovid19inspain
AT vidaurtelloloretovidaur deployingunsupervisedclusteringanalysistoderiveclinicalphenotypesandriskfactorsassociatedwithmortalityriskin2022criticallyillpatientswithcovid19inspain
AT sanchochinestasusana deployingunsupervisedclusteringanalysistoderiveclinicalphenotypesandriskfactorsassociatedwithmortalityriskin2022criticallyillpatientswithcovid19inspain
AT gonzalesdemolinafranciscojavier deployingunsupervisedclusteringanalysistoderiveclinicalphenotypesandriskfactorsassociatedwithmortalityriskin2022criticallyillpatientswithcovid19inspain
AT herrerogarciasandra deployingunsupervisedclusteringanalysistoderiveclinicalphenotypesandriskfactorsassociatedwithmortalityriskin2022criticallyillpatientswithcovid19inspain
AT senaperezcarmencarolina deployingunsupervisedclusteringanalysistoderiveclinicalphenotypesandriskfactorsassociatedwithmortalityriskin2022criticallyillpatientswithcovid19inspain
AT pozoladerasjuancarlos deployingunsupervisedclusteringanalysistoderiveclinicalphenotypesandriskfactorsassociatedwithmortalityriskin2022criticallyillpatientswithcovid19inspain
AT rodriguezgarciaraquel deployingunsupervisedclusteringanalysistoderiveclinicalphenotypesandriskfactorsassociatedwithmortalityriskin2022criticallyillpatientswithcovid19inspain
AT estellaangel deployingunsupervisedclusteringanalysistoderiveclinicalphenotypesandriskfactorsassociatedwithmortalityriskin2022criticallyillpatientswithcovid19inspain
AT ferrerricard deployingunsupervisedclusteringanalysistoderiveclinicalphenotypesandriskfactorsassociatedwithmortalityriskin2022criticallyillpatientswithcovid19inspain
AT deployingunsupervisedclusteringanalysistoderiveclinicalphenotypesandriskfactorsassociatedwithmortalityriskin2022criticallyillpatientswithcovid19inspain